Wednesday’s Top Biotech & Medical Stocks
by H.S. AyoubBioHealth Investor.com Biotechnology CRITICAL THERAPEUTIC +21.70% LEV PHARMACEUTICALS +14.72% MOLECULAR INS PHARMA +11.40% IDERA PHARMACEUTICAL +6.71% FERMAVIR PHARMACEUTL +6.25% Diagnostic Substances AMER BIO MEDICA +12.04% INTERLEUKIN GENETICS +8.29% COLEY PHARMACEUTICAL +2.89% GENE LOGIC INC +2.83% ORCHID CELLMARK INC…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
by H.S. Ayoub
BioHealth Investor.com
Biotechnology
CRITICAL THERAPEUTIC [CRTX] +21.70%
LEV PHARMACEUTICALS [LEVP.OB] +14.72%
MOLECULAR INS PHARMA [MIPI] +11.40%
IDERA PHARMACEUTICAL [IDP] +6.71%
FERMAVIR PHARMACEUTL [FMVR.OB] +6.25%
Diagnostic Substances
AMER BIO MEDICA [ABMC] +12.04%
INTERLEUKIN GENETICS [ILI] +8.29%
COLEY PHARMACEUTICAL [COLY] +2.89%
GENE LOGIC INC [GLGC] +2.83%
ORCHID CELLMARK INC [ORCH] +2.74%
Drug Delivery
QUIGLEY CORP THE [QGLY] +5.83%
INSITE VISION INC [ISV] +2.76%
BENTLEY PHARMACEUTIC [BNT] +2.35%
NOVADEL PHARMA INC [NVD] +1.50%
PETMED EXPRESS INC [PETS] +1.44%
Drug Manufacturers
JAVELIN PHARMACEUTIC [JAV] +14.26%
AVI BIOPHARMA INC [AVII] +9.76%
SOMAXON PHARMACEUTIC [SOMX] +7.05%
CELL THERAPEUTICS [CTIC] +6.17%
UNITED THERAPEUTIC [UTHR] +3.34%
Medical Appliances & Equipment
MEDICALCV INC [MCVI.OB] +16.67%
THERMAGE, INC. [THRM] +6.83%
MEDICAL ACTION IND [MDCI] +3.80%
HANSEN MEDICAL, INC. [HNSN] +3.43%
TRIMEDYNE INC [TMED.OB] +3.33%
Medical Instruments & Supplies
BIOFORCE NANOSCIENCE [BFNH.OB] +10.71%
MILESTONE SCIENTIFIC [MLSS.OB] +7.14%
ROCHESTER MEDICAL [ROCM] +5.16%
OPHTHALMIC IMAGING SYS INC [OISI.OB] +3.85%
VIVUS INC [VVUS] +3.56%
Medical Laboratories & Research
ERESEARCHTECHNOLOG [ERES] +3.65%
GENOMIC HEALTH, INC. [GHDX] +1.63%
ARRAY BIOPHARMA IN [ARRY] +1.31%
PSYCHEMEDICS NEW [PMD] +0.85%
BIO-REFERENCE LAB [BRLI] +0.68%
http://www.biohealthinvestor.com/
Contact [email protected] for any questions or corrections.
Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.
McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.
His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.
A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.
TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.
McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.